tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Income Statement

Compare
2,133 Followers

Aquestive Therapeutics Income Statement

Last quarter (Q4 2024), Aquestive Therapeutics's total revenue was $11.87M, a decrease of -10.14% from the same quarter last year. In Q4, Aquestive Therapeutics's net income was $-17.05M. See Aquestive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 57.56M$ 50.58M$ 47.68M$ 50.83M$ 45.85M
Gross Profit
$ 39.69M$ 29.75M$ 28.29M$ 35.84M$ 32.88M
Operating Expenses
$ 70.46M$ 44.85M$ 70.36M$ 70.52M$ 75.78M
Depreciation and Amortization
$ 718.00K$ 1.34M$ 2.39M$ 2.96M$ 3.61M
EBITDA
$ -26.62M$ 1.18M$ -39.58M$ -45.11M$ -39.15M
Operating Income
$ -30.77M$ -15.10M$ -42.07M$ -34.68M$ -42.89M
Other Income/Expenses
$ -13.38M$ 7.48M$ -12.34M$ -35.86M$ -12.89M
Pretax Income
$ -44.15M$ -7.63M$ -54.41M$ -70.54M$ -55.78M
Net Income
$ -44.14M$ -7.87M$ -60.20M$ -90.04M$ -65.36M
Per Share Metrics
Basic EPS
$ -0.51$ -0.13$ -1.24$ -2.36$ -1.94
Diluted EPS
$ -0.51$ -0.13$ -1.24$ -2.36$ -1.94
Weighted Average Shares Outstanding
86.73M 61.26M 48.73M 38.08M 33.65M
Weighted Average Shares Outstanding (Diluted)
86.73M 61.26M 48.73M 38.08M 33.65M
Currency in USD

Aquestive Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis